J L Izzo

Summary

Affiliation: University at Buffalo
Country: USA

Publications

  1. ncbi Differences in mean and variability of heart rate and ambulatory rate-pressure product when valsartan or carvedilol is added to lisinopril
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, Erie County Medical Center, Buffalo, NY, USA
    J Am Soc Hypertens 6:399-404. 2012
  2. ncbi Hemodynamic and central blood pressure differences between carvedilol and valsartan added to lisinopril at rest and during exercise stress
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, Erie County Medical Center, Buffalo, NY 14215, USA
    J Am Soc Hypertens 6:117-23. 2012
  3. ncbi Prehypertension: demographics, pathophysiology, and treatment
    Joseph L Izzo
    State University of New York at Buffalo, Erie County Medical Center, 462 Grider Street, Buffalo, NY 14216, USA
    Curr Hypertens Rep 9:264-8. 2007
  4. ncbi Seasonal variation in haemodynamics and blood pressure-regulating hormones
    K J Radke
    Department of Medicine, Erie County Medical Center, 462 Grider Street, Buffalo, NY 14215, USA
    J Hum Hypertens 24:410-6. 2010
  5. ncbi Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension
    J L Izzo
    Department of Medicine, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA
    J Hum Hypertens 24:403-9. 2010
  6. ncbi Are there benefits of antihypertensive therapy beyond blood pressure lowering?
    Joseph L Izzo
    Erie County Medical Center, State University of New York at Buffalo, 462 Grider Street, Buffalo, NY 14215, USA
    Curr Hypertens Rep 12:440-7. 2010
  7. ncbi Combined aliskiren-amlodipine treatment for hypertension in African Americans: clinical science and management issues
    Joseph L Izzo
    Department of Medicine, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, 462 Grider Street, Buffalo, NY 14215, USA
    Ther Adv Cardiovasc Dis 5:169-78. 2011
  8. ncbi Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure
    Joseph L Izzo
    State University of New York at Buffalo, Buffalo, NY 14215, USA
    Med Clin North Am 88:1257-71. 2004
  9. ncbi Angiotensin-converting enzyme inhibitors
    Joseph L Izzo
    Erie County Medical Center and SUNY Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, USA
    J Clin Hypertens (Greenwich) 13:667-75. 2011
  10. ncbi Benefits of antihypertensive drugs when blood pressure is below 140/90 mmHg
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, Buffalo, New York, USA
    Pol Arch Med Wewn 121:303-9. 2011

Detail Information

Publications63

  1. ncbi Differences in mean and variability of heart rate and ambulatory rate-pressure product when valsartan or carvedilol is added to lisinopril
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, Erie County Medical Center, Buffalo, NY, USA
    J Am Soc Hypertens 6:399-404. 2012
    ..These effects may contribute to the outcome benefits observed with β-blocker-ACE inhibitor combinations...
  2. ncbi Hemodynamic and central blood pressure differences between carvedilol and valsartan added to lisinopril at rest and during exercise stress
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, Erie County Medical Center, Buffalo, NY 14215, USA
    J Am Soc Hypertens 6:117-23. 2012
    ..Adding V or C to an angiotensin-converting enzyme inhibitor reduced cardiac workload by different mechanisms: vasodilation and reduced central blood pressure with V and lower heart rate with C...
  3. ncbi Prehypertension: demographics, pathophysiology, and treatment
    Joseph L Izzo
    State University of New York at Buffalo, Erie County Medical Center, 462 Grider Street, Buffalo, NY 14216, USA
    Curr Hypertens Rep 9:264-8. 2007
    ..Associated elevated risk conditions (prediabetes, hypercholesterolemia, microalbuminuria) may justify early use of ARB therapy (in men and in women without childbearing potential) if weight control fails...
  4. ncbi Seasonal variation in haemodynamics and blood pressure-regulating hormones
    K J Radke
    Department of Medicine, Erie County Medical Center, 462 Grider Street, Buffalo, NY 14215, USA
    J Hum Hypertens 24:410-6. 2010
    ..There are dramatic counterregulatory haemodynamic and hormonal adaptations to maintain a relatively constant BP. Norepinephrine, PRA, and aldosterone have a function in mediating the changes in haemodynamics...
  5. ncbi Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension
    J L Izzo
    Department of Medicine, State University of New York at Buffalo, 462 Grider St, Buffalo, NY 14215, USA
    J Hum Hypertens 24:403-9. 2010
    ..We conclude that titration of amlodipine and benazepril in single-pill combinations is more effective than titration of amlodipine alone for rapid BP control in patients with severe hypertension...
  6. ncbi Are there benefits of antihypertensive therapy beyond blood pressure lowering?
    Joseph L Izzo
    Erie County Medical Center, State University of New York at Buffalo, 462 Grider Street, Buffalo, NY 14215, USA
    Curr Hypertens Rep 12:440-7. 2010
    ..The mandate for BP reduction remains strong in virtually all clinical situations. Because of clinical heterogeneity, however, no single drug class is preferred in all circumstances...
  7. ncbi Combined aliskiren-amlodipine treatment for hypertension in African Americans: clinical science and management issues
    Joseph L Izzo
    Department of Medicine, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, 462 Grider Street, Buffalo, NY 14215, USA
    Ther Adv Cardiovasc Dis 5:169-78. 2011
    ....
  8. ncbi Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure
    Joseph L Izzo
    State University of New York at Buffalo, Buffalo, NY 14215, USA
    Med Clin North Am 88:1257-71. 2004
    ....
  9. ncbi Angiotensin-converting enzyme inhibitors
    Joseph L Izzo
    Erie County Medical Center and SUNY Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, USA
    J Clin Hypertens (Greenwich) 13:667-75. 2011
    ....
  10. ncbi Benefits of antihypertensive drugs when blood pressure is below 140/90 mmHg
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, Buffalo, New York, USA
    Pol Arch Med Wewn 121:303-9. 2011
    ....
  11. ncbi Value of Angiotensin receptor blocker therapy in diabetes
    Joseph L Izzo
    Department of Medicine, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14215, USA
    J Clin Hypertens (Greenwich) 13:290-5. 2011
    ..Thus, ARB therapy is a highly attractive alternative for individuals at any stage of diabetes and with any pattern of complications...
  12. ncbi Treating systolic hypertension in the very elderly with valsartan-hydrochlorothiazide vs. either monotherapy: ValVET primary results
    Joseph L Izzo
    State University of New York at Buffalo, Buffalo, NY, USA
    J Clin Hypertens (Greenwich) 13:722-30. 2011
    ..Thiazide monotherapy was more effective than angiotensin receptor blocker monotherapy (by about 5 mm Hg), but greater antihypertensive efficacy was achieved by initiating treatment with combination valsartan/HCTZ in the elderly...
  13. ncbi 24-hour efficacy and safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: the TRINITY ambulatory blood pressure substudy
    Joseph L Izzo
    State University of New York at Buffalo, Buffalo, NY 14215, USA
    J Clin Hypertens (Greenwich) 13:873-80. 2011
    ..The authors conclude that the triple combination of OM 40 mg/AML 10 mg/HCTZ 25 mg demonstrated superior efficacy and sustained reductions in ABP compared with its dual-combination components...
  14. ncbi Pet ownership, but not ace inhibitor therapy, blunts home blood pressure responses to mental stress
    K Allen
    Division of Clinical Pharmacology, Department of Medicine, State University of New York at Buffalo, USA
    Hypertension 38:815-20. 2001
    ..9 [0.92] versus 16.1 [0.58] ng. mL(-1). h(-1)). We conclude that ACE inhibitor therapy alone lowers resting blood pressure, whereas increased social support through pet ownership lowers blood pressure response to mental stress...
  15. ncbi Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitus
    B H Sung
    Department of Medicine, State University of New York and CGF Millard Fillmore Hospital, Buffalo, NY, USA
    Hypertension 34:83-8. 1999
    ..A reduction in vascular resistance may be a primary hemodynamic mechanism of the manner in which troglitazone lowers BP. Insulin sensitizers may offer potential therapeutic advantage in subjects with DM with elevated BP...
  16. ncbi Moderately obese, insulin-resistant women exhibit abnormal vascular reactivity to stress
    B H Sung
    Department of Medicine, State University of New York, and Millard Fillmore Health System, Buffalo 14209, USA
    Hypertension 30:848-53. 1997
    ..This hyperreactivity may be a marker for future hypertension in obese, normotensive, hyperinsulinemic individuals...
  17. ncbi Diameter, pressure and compliance relationships in dorsal hand veins
    B E Shykoff
    Department of Medicine, University at Buffalo, State University of New York, Buffalo, USA
    Vasc Med 6:97-102. 2001
    ..Reactivity depends on distending pressure and baseline P50. Percentage constriction is a function of initial and final P50 and of distending pressure...
  18. ncbi Estrogen improves abnormal norepinephrine-induced vasoconstriction in postmenopausal women
    B H Sung
    Department of Medicine, State University of New York and Millard Fillmore Hospital, Buffalo 14209, USA
    J Hypertens 17:523-8. 1999
    ..In the present study, we examined the role of estrogen in the blood pressure response to mental stress...
  19. ncbi Office blood pressures, arterial compliance characteristics, and estimated cardiac load
    J L Izzo
    Department of Medicine, State University of New York at Buffalo, 14209, USA
    Hypertension 38:1467-70. 2001
    ..At present, compliance-related variables provide little additional advantage over cuff BP in the office estimation of cardiac work...
  20. ncbi Titration of HCTZ to 50 mg daily in individuals with stage 2 systolic hypertension pretreated with an angiotensin receptor blocker
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, Buffalo, NY 14215, USA
    J Clin Hypertens (Greenwich) 9:45-8. 2007
    ..There was a dose-dependent increase in uric acid but no acute gout attacks. OM 40/HCTZ 50 mg/d is an effective strategy for managing stage 2 systolic hypertension...
  21. ncbi Efficacy and safety of treating stage 2 systolic hypertension with olmesartan and olmesartan/HCTZ: results of an open-label titration study
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, Buffalo, NY 14215, USA
    J Clin Hypertens (Greenwich) 9:36-44. 2007
    ..The authors conclude that an OM-based regimen, with or without HCTZ in conventional doses, is effective in controlling and normalizing BP in stage 2 systolic hypertension...
  22. ncbi The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report
    Aram V Chobanian
    Department of Medicine, Boston University School of Medicine, Boston, Mass, USA
    JAMA 289:2560-72. 2003
    ..Empathy builds trust and is a potent motivator. Finally, in presenting these guidelines, the committee recognizes that the responsible physician's judgment remains paramount...
  23. ncbi Sympathoadrenal activity, catecholamines, and the pathogenesis of vasculopathic hypertensive target-organ damage
    J L Izzo
    Department of Medicine, State University of New York, Buffalo
    Am J Hypertens 2:305S-312S. 1989
    ..Choosing the optimal antihypertensive drugs may require considering the impact of the drugs on the sympathoadrenal system...
  24. ncbi The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function
    J L Izzo
    Department of Medicine, State University of New York at Buffalo, Buffalo, NY 14209, USA
    Heart Dis 2:380-3. 2000
    ....
  25. ncbi Hemodynamics of seasonal adaptation
    J L Izzo
    Department of Medicine, University of Rochester School of Medicine and Dentistry, New York
    Am J Hypertens 3:405-7. 1990
    ..Thus, in the northern US, wintertime vasoconstriction is related to increased sympathetic nervous activity and decreased cardiac output. When these reciprocal changes are proportional, blood pressure remains constant...
  26. ncbi Antihypertensive efficacy of candesartan-lisinopril in combination vs. up-titration of lisinopril: the AMAZE trials
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, 462 Grider Street, Buffalo, NY 14215, USA
    J Clin Hypertens (Greenwich) 6:485-93. 2004
    ..In conclusion, for hypertensive patients not controlled by lisinopril 20 mg once daily, addition of candesartan (32 mg once daily) or doubling the dose of lisinopril provides safe, additional reduction of blood pressure...
  27. ncbi Arterial stiffness and the systolic hypertension syndrome
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, Buffalo, New York, USA
    Curr Opin Cardiol 19:341-52. 2004
    ..This review is intended to provide the background for a new comprehensive hemodynamic view of the syndrome of systolic or wide pulse pressure hypertension and its hallmark abnormality: increased central arterial stiffness...
  28. ncbi Aging and arterial structure-function relations
    Joseph L Izzo
    State University of New York at Buffalo, Buffalo, NY 14209, USA
    Adv Cardiol 44:19-34. 2007
    ..In the microcirculation, vasoconstriction, VSM hypertrophy and rarefaction accompany and may contribute to changes in organ function...
  29. ncbi Calcium channel blockers in hypertension. Is there still a controversy?
    Joseph L Izzo
    Clinical Pharmacology Division, Department of Medicine, State University of New York at Buffalo, Buffalo, USA
    Aging Clin Exp Res 17:1-5. 2005
    ..Combinations of CCBs with "anti-neurohumoral" drugs such as ACE inhibitors are particularly useful to achieve sustained blood pressure control, reduce adverse effects such as edema, and improve outcomes...
  30. ncbi Acid-suppressive therapy use associated with antihypertensive agents
    S L Chow
    School of Pharmacy, University at Buffalo, State University of New York, Buffalo, New York, USA
    J Clin Pharmacol 41:750-6. 2001
    ..Within the class of CCBs, there was no significant difference among the individual agents. As the clinical and economic burden may be substantial, further study is warranted...
  31. ncbi Systolic hypertension, arterial stiffness, and vascular damage: role of the renin-angiotensin system
    J L Izzo
    Department of Medicine and Clinical Pharmacology Division, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA
    Blood Press Monit 5:S7-11. 2000
    ..The pharmacologic interruption of the renin-angiotensin system may therefore confer previously unrecognized benefits on age-related vascular damage, providing special benefits in systolic hypertension...
  32. ncbi Arterial stiffness: clinical relevance, measurement, and treatment
    J L Izzo
    State University of New York at Buffalo, USA
    Rev Cardiovasc Med 2:29-34, 37-40. 2001
    ..Recent developments, however, suggest that improved clinical recognition of age-related vascular stiffening will lead to better therapy and improved outcomes for patients with hypertension...
  33. ncbi Humoral effect of norepinephrine on renin release in humans
    M R Licht
    Department of Medicine, University of Rochester Medical Center, New York
    Am J Hypertens 2:788-91. 1989
    ..02). This differential effect of alpha-agonists on PRA defines an important humoral effect of NE, which should be considered to be a "cardiovascular hormone."..
  34. ncbi Clinical impact of renin-angiotensin system blockade: angiotensin-converting enzyme inhibitors vs. angiotensin receptor antagonists
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, Buffalo, NY 14209, USA
    J Clin Hypertens (Greenwich) 4:11-9, 31. 2002
    ....
  35. ncbi Your drug, my drug, or our drugs: how aggressive should we be with antihypertensive therapy?
    Joseph L Izzo
    Erie County Medical Center and the Department of Medicine, Division of Clinical Pharmacology, State University of New York at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY 14215, USA
    J Clin Hypertens (Greenwich) 7:5-7. 2005
    ..In summary, why would an astute clinician (or informed patient) be satisfied with the relatively limited effects of any single class of antihypertensive agents when better overall protection is possible?..
  36. ncbi Pulse contour analysis and augmentation index: it's time to move beyond cuff blood pressure measurement
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, Buffalo, New York, USA
    Am J Hypertens 18:1S-2S. 2005
  37. ncbi ASH position paper: treatment of hypertension in patients with diabetes-an update
    George L Bakris
    Hypertensive Diseases and Diabetes Center, Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, USA
    J Clin Hypertens (Greenwich) 10:707-13; discussion 714-5. 2008
    ..Last, an updated algorithm is provided that incorporates many of the new findings and is suggested as a starting point to achieve blood pressure goals...
  38. ncbi Effects of cholesterol reduction on BP response to mental stress in patients with high cholesterol
    B H Sung
    Department of Medicine, State University of New York and Millard Fillmore Health Care System, Buffalo 14209, USA
    Am J Hypertens 10:592-9. 1997
    ..Decreased BP reactivity during HMG-CoA reductase inhibitor therapy suggests that lowering cholesterol may have a role in the overall control of BP...
  39. ncbi Hypertension in the metabolic syndrome and diabetes: pathogenesis, clinical studies, and treatment
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, Buffalo, NY 14209, USA
    J Clin Hypertens (Greenwich) 5:3-10. 2003
    ....
  40. ncbi ASH Position Paper: Dietary approaches to lower blood pressure
    Lawrence J Appel
    Department of Medicine, Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD 21205 2223, USA
    J Clin Hypertens (Greenwich) 11:358-68. 2009
    ..The current challenge is designing and implementing effective clinical and public health interventions that lead to sustained dietary changes among individuals and more broadly in the general population...
  41. ncbi Improved medical records improve hypertension management: a wake up call to payers and providers
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, 14209, USA
    J Clin Hypertens (Greenwich) 4:413-4. 2002
  42. ncbi Is postural adaptation impaired by hardened arteries?
    Joseph L Izzo
    Department of Medicine, State University of New York at Buffalo, Buffalo, NY 14215, USA
    Am J Geriatr Cardiol 14:262-4. 2005
  43. ncbi Validity and reliability of diastolic pulse contour analysis (windkessel model) in humans
    Timothy S Manning
    Division of Clinical Pharmacology, Department of Medicine, State University of New York at Buffalo, NY, USA
    Hypertension 39:963-8. 2002
    ..The validity and utility of Windkessel-derived variables is further diminished by the absence of between-site correlations and the common occurrence of uninterpretable values in hypertensive subjects...
  44. ncbi Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study
    Gary F Mitchell
    Cardiovascular Engineering, Inc, Holliston, Mass 01746, USA
    Circulation 105:2955-61. 2002
    ....
  45. ncbi Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study
    Yves Allemann
    Department of Cardiology, Swiss Cardiovascular Center Bern, University Hospital, Inselspital, Bern, Switzerland
    J Clin Hypertens (Greenwich) 10:185-94. 2008
    ..These results provide support for the BP-lowering benefits of complementary antihypertensive therapy with amlodipine and valsartan in patients with hypertension uncontrolled by previous monotherapy...
  46. ncbi Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship
    Gary F Mitchell
    Cardiovascular Engineering, Inc, 327 Fiske St, Holliston, Mass 01746, USA
    Circulation 108:1592-8. 2003
    ....
  47. ncbi Hypertensive emergencies
    Marvin Moser
    Yale University School of Medicine, New Haven, CT, USA
    J Clin Hypertens (Greenwich) 8:275-81. 2006
    ..Joseph L. Izzo, Jr., Professor of Medicine at the State University of New York at Buffalo, Buffalo, NY, and Dr. John Bisognano, Associate Professor of Medicine at the University of Rochester School of Medicine, Rochester, NY...
  48. ncbi Changes in aortic stiffness and augmentation index after acute converting enzyme or vasopeptidase inhibition
    Gary F Mitchell
    Cardiovascular Engineering, Inc, Waltham, MA 02453, USA
    Hypertension 46:1111-7. 2005
    ..Our findings indicate that AI is a complex surrogate marker that is inversely related to changes in proximal aortic stiffness in systolic hypertension...
  49. ncbi Expanding the definition and classification of hypertension
    Thomas D Giles
    Louisiana State University School of Medicine, New Orleans, LA 70112, USA
    J Clin Hypertens (Greenwich) 7:505-12. 2005
    ..We believe it would be preferable to classify all individuals as either normal or hypertensive, based on their cardiovascular evaluation, using the four categories of normal and stages 1, 2, and 3 hypertension...
  50. ncbi Prehypertension--what is it and should it be treated?
    Marvin Moser
    J Clin Hypertens (Greenwich) 8:812-8. 2006
  51. ncbi First-step use of fixed-dose combination treatment in stage 2 hypertensive patients: has the time come?
    Michael A Weber
    SUNY Downstate College of Medicine, New York, New York, USA
    J Clin Hypertens (Greenwich) 9:276-84. 2007
  52. ncbi Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Aram V Chobanian
    Boston University School of Medicine, Boston, Mass, USA
    Hypertension 42:1206-52. 2003
    ..Positive experiences, trust in the clinician, and empathy improve patient motivation and satisfaction. This report serves as a guide, and the committee continues to recognize that the responsible physician's judgment remains paramount...
  53. ncbi Aortic diameter, wall stiffness, and wave reflection in systolic hypertension
    Gary F Mitchell
    Cardiovascular Engineering Inc, University Office Park, Bldg 2, Suite 100, 51 Sawyer Road, Waltham, MA 02453, USA
    Hypertension 51:105-11. 2008
    ..Among individuals with systolic hypertension, increased PP is primarily attributable to increased wall stiffness and reduced aortic diameter rather than premature wave reflection...
  54. ncbi Augmentation index and central aortic stiffness in middle-aged to elderly individuals
    Mitul Vyas
    Cardiovascular Engineering, Inc, Waltham, Massachusetts 02453, USA
    Am J Hypertens 20:642-7. 2007
    ..We evaluated this hypothesis by investigating relations between AI and other direct measures of aortic stiffness...
  55. ncbi The role of therapeutic inertia and the use of fixed-dose combination therapy in the management of hypertension
    Jan Basile
    Ralph H. Johnson VA Medical Center, Charleston, SC, USA
    J Clin Hypertens (Greenwich) 9:636-45. 2007
  56. ncbi Plasma renin measurement in the management of hypertension: the V and R hypothesis
    Marvin Moser
    J Clin Hypertens (Greenwich) 5:373-6. 2003
  57. ncbi Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study
    Hermann Haller
    Nephrology Section, Hanover Medical School, Hanover, Germany
    J Hypertens 24:403-8. 2006
    ..The ROADMAP study will answer the question whether an ARB can prevent or delay the onset of microalbuminuria and whether this translates into protection against cardiovascular events and renal disease...
  58. ncbi Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing
    William J Elliot
    Department of Preventive Medicine, Rush Medical College of Rush University, Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 6:553-9; quiz 560-1. 2004
    ....
  59. ncbi Pulsology rediscovered: commentary on the Conduit Artery Function Evaluation (CAFE) study
    Suzanne Oparil
    Circulation 113:1162-3. 2006
  60. ncbi The use of renin inhibitors in the management of hypertension
    Marvin Moser
    Yale University School of Medicine, New Haven, CT, USA
    J Clin Hypertens (Greenwich) 9:701-5. 2007
  61. ncbi Device-guided breathing to lower blood pressure: case report and clinical overview
    William J Elliott
    Rush Medical College, Chicago, Illinois, USA
    MedGenMed 8:23. 2006
    ..Device-guided paced breathing may offer an effective, simple, and new nonpharmacologic option for treating high BP without additional side effects, but like all lifestyle modifications, must be practiced consistently to provide benefits...
  62. ncbi Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Preventi
    Clive Rosendorff
    Veterans Health Administration, USA
    Circulation 115:2761-88. 2007
  63. ncbi Stagnation and the critical need for hypertension subtyping
    Joseph L Izzo
    J Clin Hypertens (Greenwich) 10:174-5. 2008